Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds specifically to the CD20 antigen expressed on pre-B and c...
Saved in:
Main Authors: | Mariana P. Miranda-Hernández, Carlos A. López-Morales, Nancy D. Ramírez-Ibáñez, Nelly Piña-Lara, Nestor O. Pérez, Aarón Molina-Pérez, Jorge Revilla-Beltri, Luis F. Flores-Ortiz, Emilio Medina-Rivero |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/910763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
by: Mariana P. Miranda-Hernández, et al.
Published: (2018-01-01) -
Immunomodulatory Effects Mediated by Dopamine
by: Rodrigo Arreola, et al.
Published: (2016-01-01) -
Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: Ahmet B. Ergin, et al.
Published: (2012-01-01) -
Effects of Extraction Temperature on Physicochemical Properties and Antioxidant and Immunomodulatory Activities of Polysaccharides from Lycium ruthenicum Murr.
by: Bing LIU, et al.
Published: (2025-02-01) -
Rituximab for Autoimmune Encephalitis with Epilepsy
by: Mohankumar Kurukumbi, et al.
Published: (2020-01-01)